Raptor Pharmaceuticals (NASDAQ:RPTP) – A corporation that researches existing drugs to improve them through specialized drug targeting methods was up over 20% today after Lazard rated them a new “buy” and slapped a $16 price target on the stock.
I think you have to watch this name over the next few days because of the five bullet points below.
- New 52 week high today.
- Closed on the highs.
- Today’s volume was over 10x it’s 90 day average.
- Lazard has a longer term price target of $16.
- Short term targets of 5.71 and 6.99 using fib projections.
As you can see there is still room to run on the upside and using today’s low as the stop I still like the reward to risk.